
Roselin Medical provides AI-powered digital twins and synthetic data to accelerate pharmaceutical research and trial design. The platform combines AI-driven digital twins, high-fidelity synthetic datasets, and real-time dashboards to optimize trial protocols, predict outcomes, and support regulatory-compliant analysis. It serves researchers in pharma, academia, and biotechnology as a B2B platform. Key features include synthetic control groups, privacy-preserving data generation, and scalable data access with regulatory guidance. The solution targets faster development of therapies by improving data availability, trial efficiency, and decision confidence across life sciences.

Roselin Medical provides AI-powered digital twins and synthetic data to accelerate pharmaceutical research and trial design. The platform combines AI-driven digital twins, high-fidelity synthetic datasets, and real-time dashboards to optimize trial protocols, predict outcomes, and support regulatory-compliant analysis. It serves researchers in pharma, academia, and biotechnology as a B2B platform. Key features include synthetic control groups, privacy-preserving data generation, and scalable data access with regulatory guidance. The solution targets faster development of therapies by improving data availability, trial efficiency, and decision confidence across life sciences.